Abstract:Objective To investigate the mechanism of effect of melatonin (N-acetyl-5-metyoxytryptamine,MT) on anti peritoneal dialysis-related peritoneal fibrosis via regulating the TG-β1/Smad pathway.Methods Sixty rats were randomly divided into normal control groupmodel control group,low-,middle-,high-dose drug groups (n =12 each).Except normal control group,peritoneal fibrosis model was established by intraperitoneal injection of peritoneal dialysis solution containing 4.25％ glucose in rats of other groups.After modeling,0.125-,0.5-,2.0-mg · kg-1 · d-1 of MT were respectively given by gavage administration in low-,middle-,high-dose drug groups.In normal control group,equal volume of normal saline was given by intraperitoneal injection.After cultivation for 4 weeks under suitable conditions,the rats were killed,and appropriate amount of peritoneal,intestinal tissues and blood samples were taken.The changes of histopathology of peritoneal and intestinal mucosa and parietal peritoneum thickness were observed after HE and Masson trichrome staining.Immunohistochemical method was used to detect the expressions of transforming growth factor-β1 (TGF-β1),α-smooth muscle action (α-SMA),monocyte chemotactic protein 1 (MCP-1)in peritoneal tissues and Occludin protein in intestinal mucosa.Electrophoretic mobility shift assay(EMSA) was used to detect nuclear factor-kappa B(NF-κB) activity.Enzyme linked immunosorbent assay (ELISA)-sandwich technique was used to detect the concentrations of interleukin-1 (IL-1),tumor necrosis factor (TNF-α).Results The thickness of parietal peritoneum,IL-1 and TNF-α levels in rats of model control group were significantly higher than those in rats of normal control group and low-,middle-,high-dose drug groups (P ＜ 0.05,P ＜ 0.01)which in high-dose drug group were significantly lower than those in model control group and low-,middle-dose drug groups(P ＜ 0.05,P ＜ 0.01).The expression levels of TGF-β1,MCP-1,α-SMA,Occludin protein and NF-κB activity in model control group were significantly higher than those in normal control group and low-,middle-,high-dose drug groups(P ＜0.05,P ＜0.01)which in high-dose drug group were significantly lower than those in model control group and low-,middle-dose drug groups (P ＜ 0.05,P ＜ 0.01).There was no significant difference in α-SMA level between high-dose drug group and normal control group (P ＞ 0.05).Conclusions Peritoneal dialysis solution containing 4.25 ％ glucose by intraperitoneal injection can establish peritoneal fibrosis model.Melatonin can inhibit important intracellular signal regulatory factors TGF-β1 and NF-κB leading to peritoneal fibrosis thus relief peritoneal fibrosis by moderate regulation of TGF-β1/Smad pathway and inhibition of signal transduction of NF-κB.

[The Role of TGF-beta1/Smads in the Development of Peritoneal Fibrosis Induced by High Glucose Peritoneal Dialysate and LPS].

Functional and structural alterations of peritoneum and secretion of fibrotic cytokines in rats caused by high glucose peritoneal dialysis solutions.

Disruption of Low Density Lipoprotein Receptor Pathway is Involved in Peritoneal Fibrosis Induced by High Glucose Peritoneal Dialysis Solution

The mechanism by which tamoxifen attenuates high glucose-induced epithelial-to-mesenchymal transition of rat peritoneal mesothelial cells

Blockade of Thrombospondin‐1 Ameliorates High Glucose‐induced Peritoneal Fibrosis Through Downregulation of TGF‐β1/Smad3 Signaling Pathway

Autophagy Promotes Fibrosis and Apoptosis in the Peritoneum During Long-Term Peritoneal Dialysis

Integrative analysis of chromatin accessibility and transcriptome landscapes in the induction of peritoneal fibrosis by high glucose

Macrophages Regulates the Transition of Pericyte to Peritoneal Fibrosis Through the GSDMD/IL-1β Axis

The Protective Effects Of Melatonin On Peritoneal Fibrosis Induced By High Glucose Peritoneal Dialysis In Rats

Notch Activity is Increased in a Rat Peritoneal Fibrosis Model Induced by High Glucose Dialysate

Beta-Catenin Participates in Dialysate-Induced Peritoneal Fibrosis Via Enhanced Peritoneal Cell Epithelialto-Mesenchymal Transition

Effects of high glucose on human peritoneal mesothelial cells: a proteomic analysis

The Role of Peritoneal Alternatively Activated Macrophages in the Process of Peritoneal Fibrosis Related to Peritoneal Dialysis

Effect of TGF-β1 Stimulation on the Smad Signal Transduction Pathway of Human Peritoneal Mesothelial Cells.

Aberrant Wnt/Beta-Catenin Pathway Activation in Dialysate-Induced Peritoneal Fibrosis

Impact of Overexpressive Smad7 on the Infiltration of Inflammatory Cells and the Expression of Proinflammatory Factors in Peritoneum of Rat Peritoneal Fibrotic Model

Effects and significance of different glucose concentrations and LPS on the expression of VEGF and vascular proliferation in the peritoneal membrane of dialysis rat

Transforming Growth Factor Β1 Induces Epithelial–mesenchymal Transition by Activating the Jnk–SMAD3 Pathway in Rat Peritoneal Mesothelial Cells

Effect of melatonin on anti peritoneal dialysis-related peritoneal fibrosis by regulating the TG-β1/Smad pathway

Empagliflozin, a sodium glucose cotransporter-2 inhibitor, ameliorates peritoneal fibrosis via suppressing TGF-β/Smad signaling

Role of IGF-1R in Epithelial–mesenchymal Transdifferentiation of Human Peritoneal Mesothelial Cells